BASIC STAGES OF THE ON-BOARDING PROCESS TO THE EUROPEAN SYSTEM FOR VERIFICATION OF THE MEDICINAL PRODUCTS

Simple item page
creativework.keywordsEuropean hub, falsified medicines, on-boarding, serialization, verification
creativework.publisherUniversity of Chemical Technology and Metallurgyen
dc.contributor.authorKarev N.
dc.date.accessioned2024-07-16T11:16:51Z
dc.date.accessioned2024-07-16T11:19:22Z
dc.date.available2024-07-16T11:16:51Z
dc.date.available2024-07-16T11:19:22Z
dc.date.issued2021-01-01
dc.description.abstractFalsified medicines are a major threat to public health and safety. Since the falsifications become more sophisticated, the risk of falsified medicines to be proposed to patients in the EU increases every year. Such medicines represent a serious threat to global health and call for a comprehensive strategy both at European and international level. With the Falsified Medicines Directive and its supplementing Delegated Regulation the legislator has taken the necessary steps to preven falsified medicines from entering the legal supply chain. One of the measures that is being undertaken to achieve this goal is to mandate pharmaceutical companies and parallel distributors of mainly prescription medicines to apply safety features to their outer packaging. This guideline provides all manufacturers and parallel distributors with assistance in the upcoming implementation of the required measures for protection against falsification and describes in detail the on-boarding process to the European system against falsified medicines
dc.identifier.issn1314-7978
dc.identifier.issn1314-7471
dc.identifier.scopusSCOPUS_ID:85117887458en
dc.identifier.urihttps://rlib.uctm.edu/handle/123456789/1335
dc.language.isoen
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85117887458&origin=inward
dc.titleBASIC STAGES OF THE ON-BOARDING PROCESS TO THE EUROPEAN SYSTEM FOR VERIFICATION OF THE MEDICINAL PRODUCTS
dc.typeArticle
oaire.citation.issue6
oaire.citation.volume56
Files
Collections
Articles